Human immunodeficiency virus type 1 protease (HIV-1 PR) is a 99-amino acid, virally encoded protein responsible for proteolytic cleavage of viral gag and gag-pol fusion polyproteins into functional products (1-3). The activity of the protease is required for viral infectivity in vitro (4). Consequently, HIV-1 PR is an attractive therapeutic target for rational drug design (5,6), and the focus of a tremendous amount of research.
Human immunodeficiency virus type 1 protease (HIV-1 PR) is a 99-amino acid, virally encoded protein responsible for proteolytic cleavage of viral gag and gag-pol fusion polyproteins into functional products (1) (2) (3) . The activity of the protease is required for viral infectivity in vitro (4) . Consequently, HIV-1 PR is an attractive therapeutic target for rational drug design (5, 6) , and the focus of a tremendous amount of research.
HIV-1 PR has been characterized as an aspartic acid protease based on sequence homology to related enzymes (7, catalytic pH studies (8) , and inhibition by wellknown aspartyl protease inhibitors (9, 10) .
The active form of the enzyme behaves as a dimer (11, 12) . These findings have been confirmed by the elucidation of X-ray crystallographic structures of the enzyme both unbound (13) (14) (15) and bound to synthetic inhibitors (16) (17) (18) (19) (20) .
One feature that distinguishes the HIV-1 protease from cellular aspartyl proteases is the pH dependence of its activity. The optimum pH range for activity of the HIV-1 protease (4.5-6.0) (8) is considerably higher than for cellular enzymes in vitro (typically 2.0-4.0) (21) . A notable exception is human renin, which has a pH optimum in the range of 5.5-7.5 (22 
Methods
We performed molecular mechanics and dynamics calculations using a modified version ofAMBER3.0 (Revision A) (24, 25) . The all-atom force field (26) was used for all standard residues, and solvent was treated explicitly using the TIP3P model (27) . Parameters for chloride ions and zinc ions were taken from Lybrand et al. (28) and Bartolotti et al. (29) , respectively. Electrostatic and van der Waals interactions were treated using a "twin range" (9/18 A) residue-based cutoff, updated every 20 steps. We performed simulations under constant temperature (300 K) and pressure (1 bar) conditions using a 1-fsec integration time step, carried out to 200 psec.
We obtained the starting positions of the heavy atoms for the unbound and Zn2-bound dimers from the crystallographic structure of the synthetic (Aba6795) HIV-1 protease at pH 7.0 (14).
The net charge of the unbound dimer was assumed to be +4, consistent with the normal protonation states of the component amino acids at neutral pH. It is possible that the active site aspartates share a proton near neutral pH, as maximum protease activity occurs in the range 4.5-6.0 (8). However, inflections in the log V/K versus pH profile observed at pH 3.1 and 5.2 suggest one of the aspartates is protonated at pH 5.2. Since we were simulating the protease at neutral pH, we chose to treat both aspartates as being fully charged in the simulations. In the case of the zincbound protease, it is reasonable to assume that Zn2+ ion binding (pKa 9.5) (30) would involve both aspartates in the unprotonated form.
There was no particular bias in placing 2+.. 99-.I 1 -J --resulted in the placement of the Zn2+ ion in the active site cleft directly between the carboxylate side chains of the catalytic aspartate residues. The net charge of the protease and protease/ion complexes were neutralized with negatively charged chloride ions using the same procedure as for the zinc ion. The solute was solvated in a 13 A water bath (8013 water molecules) and equilibrated using the same procedures as for previous simulations (31). Unconstrained dynamics was then performed on each system at constant pressure and temperature to 200 psec.
Results Figure 1 shows the time evolution of the root mean square deviation of a carbon atoms with respect to the crystallographic structure for the molecular dynamics structures of the unbound and Zn2+-bound protease. Both systems are well equilibrated after 150 psec. The unbound protease equilibrates with a carbon root mean square deviation of about 1.5 A, whereas the Zn2-bound structure equilibrates at a lower value of approximately 1.2 A. Secondary structural analysis of the crystallographic structure and the simulation (150-200 psec) average structures was performed using the Kabsch and Sander program DSSP (32) . Of the 63 secondary structural assignments made for the crystallographic monomer, 46 (73%) were conserved in each monomer of the unbound structure, and 54 (86%) were conserved in each monomer of the Zn2+-bound structure. 2 crystallographic structure are maintained in solution both in the unbound and Zn 2-bound simulations. These include interactions at the amino-and carboxy-terminal g strands (residues 1-A, 95-99), which form a four-stranded antiparallel B sheet, and in the region of the active site triads (residues [25] [26] [27] , which interlock in the "fireman's grip" characteristic of aspartyl proteases (33). In particular, inter-subunit hydrogen bonds involving residues at or near the active site (Leu-24, Thr-26, and Arg-87) were all maintained in the presence of bound zinc. Figure 2 shows the pair distribution function (34) , gab(r), for the carboxylate oxygens of the catalytic aspartate residues (Fig.  2a ) and water oxygens (Fig. 2b) vation sphere at a distance of around 2.25 A. (35) . Figure 3 is a stereo picture of the active-site triads at the dimer interface with the Zn ion bound to the catalytic aspartates. The crystallographic structure of Wlodawer et al. (14) is also shown superimposed. Inter-subunit H bonds between Thr-26-*Leu-24' and between Thr-26 <-Thr-26' (primes indicate residues of the symmetry-related monomer), termed the "fireman's grip," are clearly maintained. Additionally, the ODI atoms of the aspartate side chains maintain H-bond contact with the backbone amino group of Gly-27 on the same strand. These H bonds are also pronounced in the crystallographic structure. The flap regions of the protease (residues 42-58), which are observed in crystallographic structures to significantly rearrange upon inhibitor binding (16) (17) (18) (19) (20) ,
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were not observed to interact with the zinc ion in the simulation. Examination of the average structure of the zinc-bound protease indicates the nearest backbone atoms of the flaps reside more than 9 A away from the zinc ion.
Discussion
Kinetic studies have shown that zinc is an effective inhibitor of renin and HIV-1 PR at pH 7, two aspartyl proteases with pH optima near neutrality (23 ) . Subsequent molecular dynamics simulations predict that the zinc ion remains stably bound in this region; i.e., no exchange of carboxylate oxygens was observed in the first coordination sphere of the zinc ion after initial equilibration. Because the hydrolysis mechanism mediated by HIV-1 PR requires one of the aspartates to be protonated, forming a hydrogen bond with the carbonyl oxygen of the scissile bond and the other in the unprotonated form to activate a water molecule for hydrolysis (6) , the coordination of both of these residues by a zinc ion would conceivably inactivate the enzyme. Gel 
